Instructions for Ricotib (Etoricoxib) pills
Brief Description
90 mg tablets: round-shaped, double-convex tablets, covered with a shell from white to white with a yellowish shade of color
Composition Etoricoxib
3 Film coated tablet, 90 mg contains: Active substance: etoricoxib - 90.0 mg. Auxiliary substances: calcium hydrophosphate, cellulose microcrystalline (type PH-102), K-28 copovidone, sodium croscarmellose, magnesium stearate. Shell tablet: opadray® II white 85F18422 (polyvinyl alcohol, titanium dioxide, macrogol-3350, talc).
Method of use and dosage Etoricoxib
Inwards, regardless of the intake of food, drinking a little water. Ethoricoxib should be used at the minimum effective dose as soon as possible at a short course. Osteoarthritis The recommended dosage is thirty mg or six ten mg once a day. Rheumatoid arthritis The recommended dose is six tenths of mg once a day. In some patients with insufficient symptom relief, taking an increased dose of ninety mg once a day may increase efficacy. Once the patient's clinical condition has stabilized, it is advisable to titrate the dose down to six tenths of mg once a day. In the absence of an increase in therapeutic activity, other treatment options should be considered. Ankylosing spondylitis
Pharmacological effect
Etoricoxib in oral administration at therapeutic concentrations is a selective inhibitor of cyclooxygenase-2 (COX-2). In clinical pharmacological studies, etoricoxib dose-dependent inhibited COX-2 without affecting COX-1 with a daily dose of up to 150 mg. Etoricoxib does not inhibit the synthesis of prostaglandins in the gastric mucosa and does not affect platelet function. Cyclooxygenase is responsible for the formation of prostaglandins
